Persistent paralysis after prolonged use of atracurium in the absence of corticosteroids

Southern Medical Journal

Volumn 89, Issue 6, 1996, Pages 624-626

  Rubio, Edmundo R ^b   Seelig, Charles B ^a  

^a GREENWICH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; CORTICOSTEROID; NEUROMUSCULAR BLOCKING AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CHEMICALLY INDUCED DISORDER; HUMAN; MALE; PARALYSIS;

ADRENAL CORTEX HORMONES; ADULT; ATRACURIUM; HUMANS; MALE; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PARALYSIS; RESPIRATION, ARTIFICIAL;

EID: 0030159592     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-199606000-00015     Document Type: Article

References (15)

1. Sunder N, Martyn J: Muscle relaxants. The Pharmacologic Approach to the Critically Ill Patient. Chernow B (ed). Baltimore, Williams & Wilkins, 3rd Ed, 1994, pp 309-320
2. Prielipp RC, Coursin DB: Applied pharmacology of common neuromuscular blocking agents in critical care. New Horizons 1994; 2:34-47
3. Buck ML, Reed MD: Use of nondepolarizing neuromuscular blocking agent in mechanically ventilated patients. Clin Pharmacol 1991; 10:32-48
4. Hirano M, Ott BR, Raps EC, et al: Acute quadriplegic myopathy: a complication of treatment with steroids, non-depolarizing blocking agents or both. Neurology 1992; 42:2082-2087
5. Barolin RJ, Jackson CE, Rogers SJ, et al: Prolonged paralysis due to nondepolarization, neuromuscular blocking agents and corticosteroids. Muscle Nerve 1994; 17:647-654
6. Segredo V, Caldwell JE, Matthay MA, et al: Persistent paralysis in critically ill patients after long term administration of vecuronium. N Engl J Med 1992; 8:524-528
7. Meyer KC, Prielipp RC, Grossman JE, et al: Prolonged weakness after infusion of atracurium in two intensive care unit patients. Anesth Analg 1994; 78:772-774
8. Branney SW, Haenel JB, Moore FA, et al: Prolonged paralysis with atracurium infusion: a case report. Crit Care Med 1994; 22:1699
9. Manthous CA, Chatila W: Prolonged weakness after the withdrawal of atracurium. Am J Respir Crit Care Med 1994; 150:1441
10. Fluegel W, Iber C, Davis S, et al: Risk factors of acute myopathy in patients with severe asthma who require mechanical ventilation. Am J Respir Crit Care Med 1994; 149:A432
11. Stiller RL, Brandon BW, Cook DR: Determination of atracurium in plasma by high-performance liquid chromatography. Anesth Analg 1985; 44:38-42
12. Nigrovic V, Fox JL: Atracurium decay and the formation of laudanosine in humans. Anesthesiology 1991; 74:446-454
13. Kelly JS, MacGregor DA: Drugs acting at the cholinergic receptor. The Pharmacologic Approach to the Critically Ill Patient. Chernow B (ed). Baltimore, Williams & Wilkins, 3rd Ed, 1994, pp 539-543
14. Adt M, Saumert SH, Reimann HJ: The role of histamine in the cardiovascular effects of atracurium. Anesthesiology 1992; 68:155-160
15. Mishra Y, Ramzan J: Enhancement by cimetidine of neuromuscular paralysis induced with atracurium. Arch Int Pharmacodyn Ther 1992; 318:97-106